Chia, Yook-ChinYook-ChinChiaTurana, YudaYudaTuranaSukonthasarn, ApichardApichardSukonthasarnZhang, YuqingYuqingZhangShin, JinhoJinhoShinCheng, Hao-MinHao-MinChengTay, Jam ChinJam ChinTayTsoi, KelvinKelvinTsoiSiddique, SaulatSaulatSiddiqueVerma, NarsinghNarsinghVermaBuranakitjaroen, PeeraPeeraBuranakitjaroenSogunuru, Guru PGuru PSogunuruNailes, JenniferJenniferNailesVan Minh, HuynhHuynhVan MinhPark, SunghaSunghaParkTeo, Boon WBoon WTeoChen, Chen-HuanChen-HuanChenTZUNG-DAU WANGSoenarta, Arieska AArieska ASoenartaHoshide, SatoshiSatoshiHoshideWang, Ji-GuangJi-GuangWangKario, KazoumiKazoumiKario2022-01-212022-01-212021-031524-6175https://scholars.lib.ntu.edu.tw/handle/123456789/592776Guidelines on the management of hypertension have been developed by various professional bodies and institutions to primarily address the issues of diagnosis, treatment, and control in order to rationalize and improve the management of hypertension. Hypertension guidelines across the world have recently been updated following the new and controversial lower blood pressure threshold of ≥130/80 mmHg for the diagnosis of hypertension adopted by the Americans. While there are differences between the major as well as between the Asian national guidelines, there were also many similarities. This paper discusses and highlights the differences and similarities between the major international guidelines of the American College of Cardiology/American Heart Association, of the European Society of Cardiology/European Society of Hypertension, and of the International Society of Hypertension and also compares them with the Asian guidelines.enAsian countries; HOPE-Asia Network; diagnosis; guidelines; hypertension; target blood pressure[SDGs]SDG3angiotensin receptor antagonist; beta adrenergic receptor blocking agent; calcium channel blocking agent; dipeptidyl carboxypeptidase inhibitor; diuretic agent; Asia; blood pressure measurement; blood pressure monitoring; cardiovascular risk; cerebrovascular accident; chronic kidney failure; chronology; coronary artery disease; decision making; diabetes mellitus; Europe; geographic distribution; geriatrics; heart failure; Hong Kong; human; hypertension; India; Indonesia; Malaysia; medical society; multiple sclerosis; Pakistan; Philippines; practice guideline; Review; risk assessment; Singapore; Taiwan; Thailand; United States; Viet Nam; blood pressure; cardiology; hypertension; hypotension; American Heart Association; Asia; Blood Pressure; Cardiology; Humans; Hypertension; Hypotension; United Statesreview10.1111/jch.14226336345702-s2.0-85101598138WOS:000621805700001https://scholars.lib.ntu.edu.tw/handle/123456789/552591